Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
87.4M
-
Number of holders
-
105
-
Total 13F shares, excl. options
-
33.9M
-
Shares change
-
+2.38M
-
Total reported value, excl. options
-
$118M
-
Value change
-
+$9.17M
-
Put/Call ratio
-
0.06
-
Number of buys
-
64
-
Number of sells
-
-30
-
Price
-
$3.49
Significant Holders of Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI) as of Q3 2025
118 filings reported holding TOI - Oncology Institute, Inc. - Common Stock, par value $0.0001 per share as of Q3 2025.
Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI) has 105 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33.9M shares
of 87.4M outstanding shares and own 38.72% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (4.55M shares), BlackRock, Inc. (3.43M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (3.36M shares), CenterBook Partners LP (2.7M shares), Balyasny Asset Management L.P. (2.52M shares), Kanen Wealth Management LLC (1.84M shares), WEXFORD CAPITAL LP (1.57M shares), GEODE CAPITAL MANAGEMENT, LLC (1.4M shares), STATE STREET CORP (1.13M shares), and UBS Group AG (1.06M shares).
This table shows the top 105 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.